Musings From the ADA: Medtech Needs to Balance Health and Happiness in Diabetes

Posted by Andy Kach on June 15, 2017

I just came back from my first American Diabetes Association Scientific Sessions event, held June 9-13 in San Diego, and there were a number of surprising revelations about the medical device industry’s role in diabetes treatment. 


>
Read More

Four Barriers to Innovation in Diabetes Blood Glucose Monitoring

Posted by Andy Kach on July 22, 2016


Diabetes is currently one of the fastest-growing diseases facing our generation. In the U.S., diabetes’ prevalence is growing at an alarming rate, having doubled from around 11 million American cases in 2000 to around 22 million in 2014, according to the CDC. Because of the size of the market for diabetes medical devices and the high growth rate of the disease, there are a lot of eyes watching what’s happening and looking for ways to invest. Since diabetes is currently incurable, it’s a very expensive disease, particularly when it starts early in a person’s lifetime. Many medical device organizations, technology companies and entrepreneurs are looking to get their foot in the door.


>
Read More

Don’t Forget the Patient

Posted by Andy Kach on April 7, 2015

With the increased commoditization of products and the rapidly increasing “fast follower” environment in medical devices, manufacturers are struggling to find the differentiating value they can bring to their primary customers, health-care providers. While millions of dollars are spent researching what makes a doctor tick, many manufacturers may be missing a significant driver of value for health-care providers.


>
Read More